Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.
Metallo Bio has raised $202K in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Metallo Bio's investors include SFC Capital, Innovate UK, Centre for Process Innovation.
Metallo Bio is headquartered in Sheffield, United Kingdom.
Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.
Metallo Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Metallo Bio — Funding & Investors." VCBacked, April 4, 2024, https://www.vcbacked.co/company/metallo-bio. Accessed July 19, 2026.
VCBacked. (2024). Metallo Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/metallo-bio
{{cite web |title=Metallo Bio — Funding & Investors |url=https://www.vcbacked.co/company/metallo-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated